search
gene editing
Trends
- 1Epigenetic editing banishes hepatitis B virus in study●'Epigenetic' editing banishes hepatitis B virus
Researchers report that epigenetic editing can silence hepatitis B virus, effectively banishing it rather than merely suppressing it. The approach targets the virus's gene activity without cutting DNA, offering a possible route toward a functional cure for a infection that affects hundreds of millions and is a leading cause of liver cancer. Readers are discussing the promise and hurdles before human use.
- 2Single CRISPR Treatment Halves Bad Cholesterol for a Year▼One CRISPR treatment cut “bad” cholesterol in half for a full year
A one-time CRISPR gene-editing treatment cut LDL, the so-called "bad" cholesterol, roughly in half, with the effect lasting a full year after a single infusion, according to new findings reported by ScienceDaily. The results point toward a durable alternative to daily statins or repeated injections for people at risk of heart disease.
- 3Engineered mini CRISPR enzyme gets 60-fold power boost▼Engineered mini CRISPR enzyme gets a 60-fold power boost for gene editing
Scientists report engineering a miniature CRISPR enzyme that is 60 times more powerful at gene editing than before. The boost in efficiency could make compact gene-editing tools more effective for therapies and research, especially where delivery space is limited. The advance highlights ongoing efforts to shrink and strengthen CRISPR systems for medical use.
- 4Epigenetic Editing Moves Closer to Clinical Use▼Epigenetic Editing Steps Closer to the Clinic as Bioengineering Tools Mature
Epigenetic editing, which alters gene activity without changing DNA sequence, is reportedly approaching clinical application as bioengineering tools mature. Advances in gene-regulation technologies are making it feasible to target epigenetic marks precisely, opening the door to therapies for diseases rooted in gene expression rather than genetic mutations. The development signals a shift from laboratory research toward translational medicine, with researchers watching how safety and delivery challenges are addressed.
- 5What's The Latest On CRISPR Gene Editing Technology?▼What’s The Latest On CRISPR Gene Editing Technology?
CRISPR gene editing is in the spotlight as observers look for updates on the technology's progress. The field has been advancing rapidly, with approval of the first CRISPR-based therapies and ongoing research into new medical applications. Coverage is focused on where the science stands now and what developments may come next in treating genetic diseases.
- 6Anthropic claims Claude AI discovered new gene-editing enzyme▼Anthropic says Claude found a new gene-editing enzyme but science isn't confirmed
Anthropic says its Claude AI helped identify a previously unknown gene-editing enzyme, a claim that would be notable if verified. The company itself acknowledges the finding has not been independently confirmed or validated through peer review, so scientists are treating the announcement with caution until laboratory evidence backs it up.
- 7Gene editing seen as a tool against global food insecurity●The shining promise of gene editing technology in a food-insecure world
Commentary is highlighting gene editing technology as a promising answer to food insecurity worldwide. The piece argues that tools allowing precise changes to crops and livestock could help farmers produce more food under difficult conditions, including climate pressure and shrinking resources. It adds to an ongoing debate over how gene-edited foods should be regulated and accepted by the public.
- 8CRISPR-Edited Plants Need a Sustainable Innovation System▼CRISPR Beyond the Lab: Why Genome-Edited Plants Need a Sustainable Innovation System
Commentary argues that CRISPR genome-edited plants must move beyond laboratory success into a broader sustainable innovation system covering regulation, farming practice and commercialisation. The piece stresses that editing crops is only one step; lasting impact depends on infrastructure, policy and responsible deployment in agriculture.
- 9Study maps rational selection of adenine base editors for human genome editing●Rational selection of SpCas9 and variant-derived adenine base editors for human genome editing
A Nature publication describes a rational framework for choosing between SpCas9 and variant-derived adenine base editors when editing the human genome. The work aims to help researchers match editor choice to specific target sites and desired edits, improving precision in gene-editing applications. The paper is being circulated among readers following advances in CRISPR-based genome editing tools.